Purine analogues : Rationale for development, mechanisms of action, and pharmacokinetics in hairy cell leukemiaJULIUSSON, Gunnar; LILIEMARK, Jan.Hematology/oncology clinics of North America. 2006, Vol 20, Num 5, issn 0889-8588, vi-vii, 1087-1097 [13 p.]Article

Mechanisms of anti-cancer action and pharmacology of clofarabineZHENCHUK, Anna; LOTFI, Koroush; JULIUSSON, Gunnar et al.Biochemical pharmacology. 2009, Vol 78, Num 11, pp 1351-1359, issn 0006-2952, 9 p.Article

Acute myeloid leukemia in the real world: why population-based registries are neededJULIUSSON, Gunnar; LAZAREVIC, Vladimir; HÖRSTEDT, Ann-Sofi et al.Blood. 2012, Vol 119, Num 17, pp 3890-3899, issn 0006-4971, 10 p.Article

Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapseLEVIS, Mark; RAVANDI, Farhad; TALLMAN, Martin S et al.Blood. 2011, Vol 117, Num 12, pp 3294-3301, issn 0006-4971, 8 p.Article

Globalization, Climate Change, and Human HealthDAVIS, Charles E; ROSSATI, Antonella; BARGIACCHI, Olivia et al.The New England journal of medicine. 2013, Vol 369, Num 1, pp 94-96, issn 0028-4793, 3 p.Article

Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate CancerLEHMANN, Sören; BYKOV, Vladimir J. N; PAUL, Christer et al.Journal of clinical oncology. 2012, Vol 30, Num 29, pp 3633-3639, issn 0732-183X, 7 p.Article

Verification that common variation at 2q37.1, 6p25.3, 11q24.1, 15q23, and 19q13.32 influences chronic lymphocytic leukaemia riskCROWTHER-SWANEPOEL, Dalemari; MANSOURI, Mahmoud; CAMPO, Elias et al.British journal of haematology. 2010, Vol 150, Num 4, pp 473-479, issn 0007-1048, 7 p.Article

Distinct gene expression profiles in subsets of chronic lymphocytic leukemia expressing stereotyped IGHV4-34 B-cell receptorsMARINCEVIC, Millaray; MANSOURI, Mahmoud; ROSENQUIST, Richard et al.Haematologica (Roma). 2010, Vol 95, Num 12, pp 2072-2079, issn 0390-6078, 8 p.Article

Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic LeukemiaKNAUF, Wolfgang U; LISSICHKOV, Toshko; BECKER, Martin et al.Journal of clinical oncology. 2009, Vol 27, Num 26, pp 4378-4384, issn 0732-183X, 7 p.Article

Age and acute myeloid leukemia : real world data on decision to treat and outcomes from the Swedish Acute Leukemia RegistryJULIUSSON, Gunnar; ANTUNOVIC, Petar; DEROLF, Asa et al.Blood. 2009, Vol 113, Num 18, pp 4179-4187, issn 0006-4971, 9 p.Article

Cyclophosphamide Plus Dexamethasone Is an Efficient Initial Treatment Before High-dose Melphalan and Autologous Stem Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma : Results of a Randomized Comparison With Vincristine, Doxorubicin, and DexamethasoneMELLQVIST, Ulf-Henrik; LENHOFF, Stig; JOHNSEN, Hans E et al.Cancer. 2008, Vol 112, Num 1, pp 129-135, issn 0008-543X, 7 p.Article

Outcomes of reduced-intensity transplantation for chronic myeloid leukemia : an analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMTCRAWLEY, Charles; SZYDLO, Richard; KOMARNICKI, Mieczystaw et al.Blood. 2005, Vol 106, Num 9, pp 2969-2976, issn 0006-4971, 8 p.Article

A low serum level of soluble tumor necrosis factor receptor p55 predicts response to thalidomide in advanced multiple myelomaBRENNE, Anne-Tove; ROMSTAD, Lene Hejna; GIMSING, Peter et al.Haematologica (Roma). 2004, Vol 89, Num 5, pp 552-556, issn 0390-6078, 5 p.Article

Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemiaTOBIN, Gerard; THUNBERG, Ulf; SUNDSTRÖM, Christer et al.Blood. 2004, Vol 104, Num 9, pp 2879-2885, issn 0006-4971, 7 p.Article

Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemiaGUNNARSSON, Rebeqa; MANSOURI, Larry; SMEDBY, Karin Ekström et al.Haematologica (Roma). 2011, Vol 96, Num 8, pp 1161-1169, issn 0390-6078, 9 p.Article

Hematopoietic Stem Cell Transplantation Rates and Long-Term Survival in Acute Myeloid and Lymphoblastic Leukemia: Real-World Population-Based Data From the Swedish Acute Leukemia Registry 1997-2006JULIUSSON, Gunnar; KARLSSON, Karin; MÖLLGARD, Lars et al.Cancer. 2011, Vol 117, Num 18, pp 4238-4246, issn 0008-543X, 9 p.Article

Impact of age on survival after intensive therapy for multiple myeloma : a population-based study by the nordic myeloma study groupLENHOFF, Stig; HJORTH, Martin; JOHNSEN, Hans E et al.British journal of haematology. 2006, Vol 133, Num 4, pp 389-396, issn 0007-1048, 8 p.Article

The pattern of deoxycytidine- and deoxyguanosine kinase activity in relation to messenger RNA expression in blood cells from untreated patients with B-cell chronic lymphocytic leukemiaLOTFI, Kourosh; KARLSSON, Karin; FYRBERG, Anna et al.Biochemical pharmacology. 2006, Vol 71, Num 6, pp 882-890, issn 0006-2952, 9 p.Article

Outcomes for reduced-intensity allogeneic transplantation for multiple myeloma : an analysis of prognostic factors from the Chronic Leukaemia Working Party of the EBMTCRAWLEY, Charles; LALANCETTE, Marc; SUREDA, Anna et al.Blood. 2005, Vol 105, Num 11, pp 4532-4539, issn 0006-4971, 8 p.Article

Identification of a commonly amplified 4.3 Mb region with overexpression of C8FW, but not MYC in MYC-containing double minutes in myeloid malignanciesSTORLAZZI, Clelia T; FIORETOS, Thoas; PAULSSON, Kajsa et al.Human molecular genetics (Print). 2004, Vol 13, Num 14, pp 1479-1485, issn 0964-6906, 7 p.Article

Chronic lymphocytic leukemias utilizing the V_H3-21 gene display highly restricted V_λ2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitopeTOBIN, Gerard; THUNBERG, Ulf; SUNDSTRÖM, Christer et al.Blood. 2003, Vol 101, Num 12, pp 4952-4957, issn 0006-4971, 6 p.Article

Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trialKNAUF, Wolfgang U; LISSITCHKOV, Toshko; BECKER, Martin et al.British journal of haematology. 2012, Vol 159, Num 1, pp 67-77, issn 0007-1048, 11 p.Article

Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapiesAGATHANGELIDIS, Andreas; DARZENTAS, Nikos; CAHILL, Nicola et al.Blood. 2012, Vol 119, Num 19, pp 4467-4475, issn 0006-4971, 9 p.Article

Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia riskCROWTHER-SWANEPOEL, Dalemari; BRODERICK, Peter; JURLANDER, Jesper et al.Nature genetics. 2010, Vol 42, Num 2, pp 132-136, issn 1061-4036, 5 p.Article

Early response predicts thalidomide efficiency in patients with advanced multiple myelomaWAAGE, Anders; GIMSING, Peter; WISLÖFF, Finn et al.British journal of haematology. 2004, Vol 125, Num 2, pp 149-155, issn 0007-1048, 7 p.Article